ProCE Banner Activity

Managing Acute and Long-term Toxicities With CAR T-Cell Products

Slideset

Review strategies for managing acute and long-term adverse events related to CAR T-cell therapies for multiple myeloma with these downloadable slides from an expert webinar.

Released: February 22, 2023

Expiration: February 21, 2024

No longer available for credit.

Share

Faculty

Amrita Krishnan

Amrita Krishnan, MD, FACP

Director 
Judy Bernard Briskin Center for Myeloma
Executive Director
Professor
Hematology City of Hope Irvine
Duarte, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC